The therapeutic potential of RNA regulation in neurological disorders
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The therapeutic potential of RNA regulation in neurological disorders
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 22, Issue 12, Pages 1017-1028
Publisher
Informa UK Limited
Online
2018-10-30
DOI
10.1080/14728222.2018.1542429
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Macromolecule nanotherapeutics: approaches and challenges
- (2018) Puneet Tyagi et al. DRUG DISCOVERY TODAY
- Drug Distribution into Peripheral Nerve
- (2018) Houfu Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice
- (2018) Hichem Tasfaout et al. MOLECULAR THERAPY
- Congenital myopathies: disorders of excitation–contraction coupling and muscle contraction
- (2018) Heinz Jungbluth et al. Nature Reviews Neurology
- The Use of Nanoparticles for Gene Therapy in the Nervous System
- (2018) Francisco C. Pérez-Martínez et al. JOURNAL OF ALZHEIMERS DISEASE
- Structural basis for the synergy of 4′- and 2′-modifications on siRNA nuclease resistance, thermal stability and RNAi activity
- (2018) Joel M Harp et al. NUCLEIC ACIDS RESEARCH
- Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future
- (2017) Françoise Piguet et al. HUMAN GENE THERAPY
- PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models
- (2017) Hien Tran Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery
- (2017) Chaitanya R. Joshi et al. Journal of Neuroimmune Pharmacology
- Antisense oligonucleotides: the next frontier for treatment of neurological disorders
- (2017) Carlo Rinaldi et al. Nature Reviews Neurology
- Viral vectors for therapy of neurologic diseases
- (2017) Sourav R. Choudhury et al. NEUROPHARMACOLOGY
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNA editing with CRISPR-Cas13
- (2017) David B. T. Cox et al. SCIENCE
- Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
- (2017) Hichem Tasfaout et al. Nature Communications
- Eteplirsen in the treatment of Duchenne muscular dystrophy
- (2017) Kenji Rowel Lim et al. Drug Design Development and Therapy
- Gene suppression approaches to neurodegeneration
- (2017) Rhia Ghosh et al. Alzheimers Research & Therapy
- Advances in the delivery of RNA therapeutics: from concept to clinical reality
- (2017) James C. Kaczmarek et al. Genome Medicine
- The prospects of CRISPR-based genome engineering in the treatment of neurodegenerative disorders
- (2017) Jun Wan Shin et al. Therapeutic Advances in Neurological Disorders
- Deletion of exons 3−9 encompassing a mutational hot spot in the DMD gene presents an asymptomatic phenotype, indicating a target region for multiexon skipping therapy
- (2016) Akinori Nakamura et al. JOURNAL OF HUMAN GENETICS
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- MicroRNAs in epilepsy: pathophysiology and clinical utility
- (2016) David C Henshall et al. LANCET NEUROLOGY
- Inhibition of miR-203 Reduces Spontaneous Recurrent Seizures in Mice
- (2016) Soon-Tae Lee et al. MOLECULAR NEUROBIOLOGY
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- Protective role of miR-23b-3p in kainic acid-induced seizure
- (2016) Lianbo Zhan et al. NEUROREPORT
- Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
- (2016) Bailey Miskew Nichols et al. Jove-Journal of Visualized Experiments
- Upregulation of Haploinsufficient Gene Expression in the Brain by Targeting a Long Non-coding RNA Improves Seizure Phenotype in a Model of Dravet Syndrome
- (2016) J. Hsiao et al. EBioMedicine
- Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases
- (2015) M. Elizabeth Meredith et al. AAPS Journal
- Seizure suppression through manipulating splicing of a voltage-gated sodium channel
- (2015) Wei-Hsiang Lin et al. BRAIN
- Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1–9 and lentiviral vectors
- (2015) S A Hoyng et al. GENE THERAPY
- Socio-economic burden of rare diseases: A systematic review of cost of illness evidence
- (2015) Aris Angelis et al. HEALTH POLICY
- Duchenne Muscular Dystrophy: From Diagnosis to Therapy
- (2015) Maria Falzarano et al. MOLECULES
- Knocking down disease: a progress report on siRNA therapeutics
- (2015) Anders Wittrup et al. NATURE REVIEWS GENETICS
- Applications of CRISPR–Cas systems in neuroscience
- (2015) Matthias Heidenreich et al. NATURE REVIEWS NEUROSCIENCE
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- Functional roles of alternative splicing factors in human disease
- (2015) Benjamin Cieply et al. Wiley Interdisciplinary Reviews-RNA
- Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus
- (2014) Eva M. Jimenez-Mateos et al. Brain Structure & Function
- Biological stability and activity of siRNA in ionic liquids
- (2014) Romiza R. Mazid et al. CHEMICAL COMMUNICATIONS
- MiR-219 Protects Against Seizure in the Kainic Acid Model of Epilepsy
- (2014) Honghua Zheng et al. MOLECULAR NEUROBIOLOGY
- siPools: highly complex but accurately defined siRNA pools eliminate off-target effects
- (2014) Michael Hannus et al. NUCLEIC ACIDS RESEARCH
- Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients
- (2014) Niels H. Skotte et al. PLoS One
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Challenges posed to the European pharmaceutical regulatory system by highly personalized medicines
- (2013) John D. Johnston et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Characterization of Polyethylene Glycol-Polyethyleneimine as a Vector for Alpha-Synuclein siRNA Delivery to PC12 Cells for Parkinson's Disease
- (2013) Yun-Yun Liu et al. CNS Neuroscience & Therapeutics
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
- (2013) Timothy M Miller et al. LANCET NEUROLOGY
- Splicing therapy for neuromuscular disease
- (2013) Andrew G.L. Douglas et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Targeting long non-coding RNA to therapeutically upregulate gene expression
- (2013) Claes Wahlestedt NATURE REVIEWS DRUG DISCOVERY
- Nanotechnology for CNS delivery of bio-therapeutic agents
- (2013) Lipa Shah et al. Drug Delivery and Translational Research
- Investigation of the performance of PEG–PEI/ROCK-II-siRNA complexes for Alzheimer's disease in vitro
- (2012) Yunyun Liu et al. BRAIN RESEARCH
- Displaying High-affinity Ligands on Adeno-associated Viral Vectors Enables Tumor Cell-specific and Safe Gene Transfer
- (2012) Robert C Münch et al. MOLECULAR THERAPY
- Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects
- (2012) Eva M Jimenez-Mateos et al. NATURE MEDICINE
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs
- (2011) Christopher H. Thompson et al. EPILEPSIA
- The core Dravet syndrome phenotype
- (2011) Charlotte Dravet EPILEPSIA
- Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design
- (2011) J N Martin et al. GENE THERAPY
- Adeno-Associated Virus Serotype 9 Transduction in the Central Nervous System of Nonhuman Primates
- (2011) Lluis Samaranch et al. HUMAN GENE THERAPY
- Alternative Splicing Modulates Inactivation of Type 1 Voltage-gated Sodium Channels by Toggling an Amino Acid in the First S3-S4 Linker
- (2011) Emily V. Fletcher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Silencing disease genes in the laboratory and the clinic
- (2011) Jonathan K Watts et al. JOURNAL OF PATHOLOGY
- Rare neurological diseases: a united approach is needed
- (2011) The Lancet Neurology LANCET NEUROLOGY
- Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
- (2010) Jeffrey D. Rothstein ANNALS OF NEUROLOGY
- Drug delivery and nanoparticles: Applications and hazards
- (2010) de Jong International Journal of Nanomedicine
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference
- (2009) Maria Stella Lombardi et al. EXPERIMENTAL NEUROLOGY
- Alternating 2′-O-ribose methylation is a universal approach for generating non-stimulatory siRNA by acting as TLR7 antagonist
- (2009) Svetlana Hamm et al. IMMUNOBIOLOGY
- Alternative Splicing in the Voltage-Gated Sodium Channel DmNav Regulates Activation, Inactivation, and Persistent Current
- (2009) Wei-Hsiang Lin et al. JOURNAL OF NEUROPHYSIOLOGY
- Regulatory roles of natural antisense transcripts
- (2009) Mohammad Ali Faghihi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- siRNA and Innate Immunity
- (2009) Marjorie Robbins et al. OLIGONUCLEOTIDES
- Follow-up of three patients with a large in-frame deletion of exons 45–55 in the Duchenne muscular dystrophy (DMD) gene
- (2008) Akinori Nakamura et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started